The Common Inherited Kidney Disorder Every Family Should Know About
⚡ Quick Facts: Polycystic Kidney Disease (PKD) is a genetic disorder that causes numerous fluid-filled cysts to grow in the kidneys, gradually enlarging them and reducing their ability to filter blood. It affects roughly 1 in 400–1,000 people worldwide and is responsible for about 5–10% of all kidney failure cases. There are two inherited forms — ADPKD (adult-onset, ~90% of cases) and ARPKD (infantile, rare).
PKD causes clusters of fluid-filled cysts to develop primarily in the kidneys, though cysts can also form in the liver and, less commonly, the pancreas and spleen. As the cysts multiply and grow, they increase the overall size and weight of the kidneys — in severe cases an affected kidney can weigh several times more than a healthy one — while crowding out healthy, functioning tissue.
Unlike simple kidney cysts, which are common with age and usually harmless, PKD cysts keep multiplying and can seriously impair kidney function over time. This progressive damage is a leading cause of chronic kidney disease (CKD) and, eventually, kidney failure requiring dialysis or a kidney transplant.
There are two main inherited forms of PKD, which differ in how they are passed down, when symptoms appear, and how severe they are.
| Feature | 🔵 ADPKD (Adult, Dominant) | 🟠 ARPKD (Infantile, Recessive) |
|---|---|---|
| How common | ~90% of PKD cases; about 1 in 400–1,000 people | Rare — about 1 in 20,000–40,000 births |
| Genes involved | PKD1 or PKD2 | PKHD1 |
| Inheritance | Only one parent needs the mutated gene; each child has a 50% risk | Both parents must carry & pass on the mutated gene |
| Typical onset | Adulthood, usually ages 30–50 | Before birth, at birth, or in early childhood |
| ICD-10 code | Q61.2 | Q61.1 |
PKD often develops silently — nearly half of all cases are discovered only incidentally or later in life.
🔴 In Adults (ADPKD)
|
🟠 In Infants & Children (ARPKD)
|
PKD is caused by mutations in genes that normally regulate the growth of kidney tubule cells. When these genes are altered, the cells lining the kidney tubules multiply abnormally and form fluid-filled cysts instead of functioning normally.
PKD is a systemic condition — its effects often extend well beyond the kidneys.
| Complication | Risk Level |
|---|---|
| High blood pressure (hypertension) | HIGH |
| Chronic kidney disease → kidney failure | HIGH |
| Kidney stones & recurrent UTIs | MODERATE |
| Liver & pancreatic cysts | MODERATE |
| Brain (intracranial) aneurysm | HIGH |
| Heart valve abnormalities | MODERATE |
| Diverticulosis / diverticulitis | MODERATE |
| Preeclampsia (in pregnancy) | HIGH |
🚨 Seek urgent medical care if you have PKD and experience sudden severe headache, chest pain, swelling in the legs/ankles, shortness of breath, or an inability to urinate.
A nephrologist (kidney specialist) diagnoses PKD using a combination of imaging and, where needed, genetic testing:
| 🩺 | Test | What It Shows |
|---|---|---|
| 📡 | Ultrasound | First, most common test; also used for prenatal screening |
| 🖥️ | CT Scan | More detailed images; detects smaller cysts |
| 🧲 | MRI | Measures total kidney volume to track progression |
| 🧬 | Genetic Testing | Blood/saliva test confirming PKD1, PKD2, or PKHD1 mutations |
| 🩸 | Blood & Urine Tests | Assess kidney function; check for protein/blood in urine |
General reference only — actual ranges vary slightly by lab. Always review results with your doctor.
| Test | Typical Normal Range | What a Change May Suggest |
|---|---|---|
| Serum Creatinine | 0.6 – 1.3 mg/dL | ⚠ Rising = declining kidney function |
| eGFR | ≥ 90 mL/min/1.73m² | ⚠ Below 60 for 3+ months = CKD |
| Blood Urea Nitrogen (BUN) | 7 – 20 mg/dL | ⚠ Elevated = reduced filtration |
| Urinalysis — Blood/Protein | Negative / trace | ⚠ May indicate cyst bleeding or kidney damage |
| Blood Pressure | Below 120/80 mmHg | ⚠ Often the earliest sign of PKD |
| Total Kidney Volume (MRI) | Varies by age/height | ⚠ Larger volume = faster progression |
There is no cure for PKD yet, but treatment focuses on slowing progression, controlling symptoms, and managing complications.
|
|
| Parameter | Data |
|---|---|
| Global prevalence (ADPKD) | 1 in 400–1,000 people |
| Share of all PKD cases that are ADPKD | ~90% |
| ARPKD incidence | 1 in 20,000–40,000 births |
| Share of kidney failure caused by PKD | 5–10% |
| ADPKD patients needing dialysis/transplant by age 70 | ~50% |
| Tolvaptan FDA approval | 2018 (first ADPKD-specific therapy) |
🔴 Seek emergency care immediately if there is:
🟡 See a specialist if you notice:
With appropriate treatment and monitoring, many people with ADPKD live full, active lives for decades after diagnosis, though roughly half will eventually need dialysis or a transplant by around age 70. Outcomes for ARPKD vary widely — the condition can be life-threatening in the newborn period, but children who survive infancy and receive ongoing care can live for many years. Early diagnosis, blood pressure control, and newer medications like tolvaptan have meaningfully improved the outlook for many patients.
Our network of experienced nephrologists provides comprehensive diagnosis and management of Polycystic Kidney Disease — from imaging and genetic counseling to advanced medical therapy, dialysis planning and kidney transplant coordination.
📞 International Patient Helpdesk: +91-8860606766 | +91-9910655125
This article is for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified nephrologist for concerns about your kidney health.
